Johnson & Johnson (JNJ): Rep. Rick W. Allen (GA12) disclosed a sale $15K–$50K

$15,001–$50,000

Reported range · official band, not an exact amount

27 days

Disclosure lag

Traded

Jun 13, 2024

Disclosed

Jul 10, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Jul 14, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
2. Nov 10, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Jun 4, 2024Congress · 2 peopleMembers of Congress: 2 purchases
4. Jun 13, 2024 · this disclosureCongressDisclosed sale of JNJ — reported range $15,001 - $50,000

What came next

1. Jun 21, 2024CongressDisclosed partial sale of JNJ — reported range $1,001 - $15,000
2. Jul 1, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
3. Jul 2, 2024Congress · 1 personMembers of Congress: 2 purchases
4. Jul 3, 2024Congress · 1 personMembers of Congress: 2 sales
5. Jul 16, 2024CongressDisclosed sale of JNJ — reported range $15,001 - $50,000
6. Aug 2, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
7. Aug 5, 2024FDARecall: ImpellaCP SmartAssistSetAPAC, Delo1895; Product Code: 1000302;
8. Aug 5, 2024FDARecall: Impella CP Pump 371 Set, Clinical Trial; Product Code: 0048-0040;
9. Aug 6, 2024FDAFDA device clearance: Abiomed 14Fr Low Profile Introducer Kit
10. Aug 7, 2024CongressDisclosed purchase of JNJ — reported range $15,001 - $50,000
11. Aug 19, 2024FDAFDA drug approval: Rybrevant
12. Aug 19, 2024FDAFDA drug approval: Lazcluze
13. Sep 4, 2024CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
14. Sep 6, 2024FDAFDA device clearance: MENTOR™ MemoryGel™ Enhance Single Use Gel Sizer
15. Sep 9, 2024FDAFDA device clearance: TriALTIS™ Spine System
16. Sep 10, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
17. Sep 11, 2024FDAFDA drug approval: Tremfya
18. Sep 11, 2024FDAFDA device clearance: HEALIX ADVANCE Knotless anchors; HEALIX ADVANCE Self-Punching anchors
19. Sep 16, 2024FDAFDA device clearance: CROSSNAV Navigation Enabled Instruments and UNAS Navigation Arrays
20. Sep 19, 2024FDAFDA drug approval: Rybrevant

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Rick W. Allen (GA12)

• House Clerk periodic transaction report at AutoZone (AZO)Oct 14, 2026
• House Clerk periodic transaction report at Costco (COST)Oct 14, 2026
• House Clerk periodic transaction report at Broadcom (AVGO)Sep 22, 2026
• House Clerk periodic transaction report at Rollins, Inc. (ROL)Sep 22, 2026
• House Clerk periodic transaction report at Abbott Laboratories (ABT)Aug 18, 2026

The full history of Rep. Rick W. Allen (GA12) is on the profile page.

How this filing works

• The STOCK Act

Other disclosures at Johnson & Johnson

• House Clerk periodic transaction reportOct 5, 2026
• USAspending.gov award recordOct 5, 2026
• USAspending.gov award recordSep 24, 2026
• USAspending.gov award recordSep 22, 2026
• USAspending.gov award recordSep 21, 2026
• House Clerk periodic transaction reportSep 12, 2026

Everything OQRO holds on this company is on its JNJ page.